AfroCentric incorporated (80% effective interest acquired) and listed on the JSE
Acquired AfroCentric Health Group (80% effective interest)
Increased effective interest in AfroCentric Health to 94.1%
Helios IT Solutions acquired a 51% interest in Allegra
Acquired South African licence of document based care (DBC) back and neck rehabilitation programme
Acquired:
100% of Pharmacy Direct – 100% of Curasana
26% of Activo Health
Sanlam acquired 28.7% of AfroCentric Healthcare Assets, a major subsidiary of AfroCentric Investment Corporation
Awarded POLMED scheme contract
Acquired:
51% of The Cheese Has Moved (TCHM)
100% of Wellness Odyssey
Amalgamation of Bonitas and Liberty added
125 000 lives to our care
Pharmacy Direct secured further contracts for the delivery of chronic medicine to public sector patients, increasing footprint from five to seven South African provinces
Acquired:
51% of EssentialMed
80% of Scriptpharm Risk Management
70% of MMed Distribution
ADS acquired 51% of Tendahealth
COMMED merged with Bonitas
Awarded Hosmed contract
Pharmacy Direct awarded four of nine provinces in the new National Department of Health (NDoH) Central Chronic Medicine Dispensing and Distribution (CCMDD) contracts, increasing volumes from 50% to an estimated 80%
Acquired:
Remaining 74% of Activo Health
82.8% of PHA
100% of Sanlam Health (renamed AfroCentric Integrated Health Administrators)
Additional 25% of Associated Fund Administrators Botswana
Medshield Hospital and Fraud Management Bonitas Actuarial Services
Hosmed Medicine Management
POLMED contracts Scriptpharm for Chronic Medicine Management
Acquired:
Remaining 20% of Scriptpharm effective 1 August 2020
Remaining 17.2% of PHA effective 1 October 2019
Additional 17% of TCHM
DENIS effective 1 October 2020
Scriptpharm won Bonitas Chronic Medicine Management and POLMED HIV Chronic Medicine Management contracts
Medscheme won a contract to administer MEDiPOS Medical Scheme
Health administration and risk management
Expansion across healthcare value chain